Advisors Preferred, LLC Verona Pharma PLC Transaction History
Advisors Preferred, LLC
- $602 Million
- Q4 2024
A detailed history of Advisors Preferred, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Advisors Preferred, LLC holds 967 shares of VRNA stock, worth $58,977. This represents 0.01% of its overall portfolio holdings.
Number of Shares
967
Previous 2,558
62.2%
Holding current value
$58,977
Previous $73,000
39.73%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding VRNA
# of Institutions
181Shares Held
68.6MCall Options Held
704KPut Options Held
685K-
Perceptive Advisors LLC New York, NY6.32MShares$385 Million4.75% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$341 Million12.27% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.01MShares$306 Million2.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.22MShares$257 Million2.52% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$216 Million14.95% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $3.72B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...